Stock ODYY ODYSSEY HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Odyssey Health, Inc.

Equities

ODYY

US67612C1027

Delayed OTC Markets
Other stock markets
 16:37:52 26/06/2024 BST 		5-day change 1st Jan Change
0.0396 USD -18.92% Intraday chart for Odyssey Health, Inc. -27.29% -60.30%
06-14 Odyssey Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2024 CI
03-22 Odyssey Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024 CI

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Odyssey Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2024
Odyssey Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024
Oragenics, Inc. completed the acquisition of Assets related to proprietary neurological drug therapies and technologies of Odyssey Health, Inc.
Odyssey Health, Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023
Odyssey Health, Inc. Reports Earnings Results for the Full Year Ended July 31, 2023
Odyssey Health, Inc. Announces the Resignation of John Gandolfo as Director
Odyssey Health, Inc. Presents Concussion Treatment Data At the Military Health System Research Symposium -MHSRS
Odyssey Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023
Odyssey Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023
Odyssey Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023
Odyssey Health, Inc. Appoints Jeffrey Conroy as Director
Odyssey Health, Inc. to Develop Intranasal Field- Deliverable Nerve Agent Antidote
Odyssey Health, Inc. Announces Resignation of Jeffrey Conroy as Director
Odyssey Health, Inc. Reports Earnings Results for the First Quarter Ended October 31, 2022
Odyssey Health, Inc. Provides Update on Company and the Progress of Concussion Drug Development
Odyssey Health Inc. Announces Expansion of Executive Team
Odyssey Health Inc. Files Full US Patent Application on Novel Breath-Propelled Intranasal Brain-Drug Delivery Device
Odyssey Health, Inc. Reports Earnings Results for the Full Year Ended July 31, 2022
Odyssey Health, Inc. Auditor Raises 'Going Concern' Doubt
Odyssey Health, Inc. Forms Pharmaceutical Subsidiary Focused on Treating Neurological Diseases
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ODYY Stock
  4. News Odyssey Health, Inc.
  5. Other languages